Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bhavya Chebrolu"'
Autor:
Roopa Satyanarayan Basutkar, Chris Elizabeth Vinod, Shruthi Jaya Saju, Bhavya Chebrolu, Sivasankaran Ponnusankar
Publikováno v:
Annals of Indian Academy of Neurology, Vol 24, Iss 2, Pp 155-163 (2021)
Background: The current target of migraine treatment is focused on Triptans. Lasmiditan, a non-vasoconstrictive and highly selective 5HT1F receptor agonist is a novel therapeutic discovery for migraine for patients with cardiovascular (CV) risk facto
Externí odkaz:
https://doaj.org/article/3ede3382aa634c53ab9e8c9849fe932d
Autor:
Sivasankaran Ponnusankar, Bhavya Chebrolu, Roopa Satyanarayan Basutkar, Chris Elizabeth Vinod, Shruthi Jaya Saju
Publikováno v:
Annals of Indian Academy of Neurology, Vol 24, Iss 2, Pp 155-163 (2021)
Annals of Indian Academy of Neurology
Annals of Indian Academy of Neurology
Background: The current target of migraine treatment is focused on Triptans. Lasmiditan, a non-vasoconstrictive and highly selective 5HT1F receptor agonist is a novel therapeutic discovery for migraine for patients with cardiovascular (CV) risk facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae7361cb4294ecc50c16dc2140e1dc5
http://www.annalsofian.org/article.asp?issn=0972-2327
http://www.annalsofian.org/article.asp?issn=0972-2327
Autor:
Swathi Swaroopa Borra, Bhavya Chebrolu, Poojitha Thotakura, Sujin Bright Francis Joice, Vasanth Raj Palanimuthu, Sadagoban Gopal Krishnamoorthy, Arun Kanniyappan Parthasarathy
Publikováno v:
Journal of Applied Pharmaceutical Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::146abf46de46c67153f67edb26c8d295
https://doi.org/10.7324/japs.2021.1101006
https://doi.org/10.7324/japs.2021.1101006